19692-00-3 Usage
General Description
3-(1,3-thiazol-2-ylcarbamoyl)propanoic acid is a chemical compound with the molecular formula C7H9N3O3S. It is a thiazole-based compound that contains a thiazol-2-ylcarbamoyl group and a propanoic acid group. 3-(1,3-thiazol-2-ylcarbamoyl)propanoic acid is used in the synthesis of pharmaceuticals and agrochemicals, as well as in the development of new materials and bioactive molecules. It has also been studied for its potential biological and pharmacological properties, including antifungal and antibacterial activities. The compound may have potential applications in the medical and agricultural fields, as well as in materials science.
Check Digit Verification of cas no
The CAS Registry Mumber 19692-00-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,9,6,9 and 2 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 19692-00:
(7*1)+(6*9)+(5*6)+(4*9)+(3*2)+(2*0)+(1*0)=133
133 % 10 = 3
So 19692-00-3 is a valid CAS Registry Number.
InChI:InChI=1/C7H8N2O3S/c10-5(1-2-6(11)12)9-7-8-3-4-13-7/h3-4H,1-2H2,(H,11,12)(H,8,9,10)
19692-00-3Relevant articles and documents
Carboxamide compound and preparation method and application thereof
-
Paragraph 0060-0063, (2017/08/29)
The invention discloses a carboxamide compound and a preparation method and an application thereof. The structural formula of the carboxamide compound is as shown in a formula I. A related activity test result verifies that the compound as shown in the formula I has brassinolide related activity in a plant body and can be applied further as a plant growth regulator. The formula I is as shown in the specification.
Amide derivatives and methods of their use
-
Page/Page column 38, (2008/06/13)
Amide derivatives of the general formulae Ia and Ib: are disclosed. Pharmaceutical compositions containing these compounds, and methods for their use, inter alia, for treating and/or preventing gastrointestinal disorders, pain, and pruritus are also disclosed.
